Abstract: An example of an apparatus to transport utility-scale lithium-ion batteries in a racked and operational state. The apparatus includes a base and an isolation platform. In addition, the apparatus includes an isolator mounted on the base to support the isolation platform. The isolator is to dampen forces exerted on the isolation platform from the base. Furthermore, the apparatus includes a rack mounted onto the isolation platform. The rack is to secure a plurality of lithium-ion batteries to store energy at a utility-scale to be provided to a power distribution network. The plurality of lithium-ion batteries is racked in an operational state during transportation.

Abstract: An example of an apparatus to connect a power distribution network with an energy storage unit. The apparatus includes a mobile platform. In addition, the apparatus includes a connection system to connect with an energy storage unit and to receive a current from the energy storage unit. Furthermore, the apparatus includes a transformer mounted on the mobile platform to convert the voltage from the connection system to the voltage of a power distribution network. The apparatus also includes an output cable to connect with the power distribution network.

Abstract: An example of a system to provide energy storage capacity moveable between multiple locations is provided. The system includes a plurality of docking stations, wherein each docking station is connected to a power distribution network. In addition, the system includes an energy storage unit to connect to a first docking station selected from the plurality of docking stations. Furthermore, the system includes a transporter onto which the energy storage unit is mounted to transport the energy storage unit from the first docking station to a second docking station.

Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.

Abstract: The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus.

Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.

Abstract: A system, method, and computer-readable medium for an information technology (IT) ecosystem management and monitoring operation. The IT ecosystem management and monitoring operation includes: executing a sustainability application on a hardware processor of an information handling system; providing an IT ecosystem monitoring and management console, the IT ecosystem monitoring and management console comprising an IT ecosystem sustainability system, the IT ecosystem sustainability system comprising a sustainability component; and, communicating between the sustainability component and the sustainability application to perform an IT environment sustainability operation.

Abstract: A system, method, and computer-readable medium for an information technology (IT) ecosystem management and monitoring operation. The IT ecosystem management and monitoring operation includes: providing a sustainability application to an information handling system, the information handling system comprising a modular component architecture; obtaining sustainability information regarding a component of the information handling system via the sustainability application; providing an IT ecosystem monitoring and management console, the IT ecosystem monitoring and management console comprising an IT ecosystem sustainability system, the IT ecosystem sustainability system comprising a sustainability component; and, communicating between the sustainability component and the sustainability application to perform an IT environment sustainability operation, the communicating providing the sustainability component with the sustainability information regarding the component of the information handling system.

Abstract: Methods, systems, and apparatuses are described herein for the direct sharing and use of transaction data separately from transaction authorization processes. Transaction metadata associated with a transaction may be received and validated. Authorization information corresponding to the transaction may be received. The degree to which the transaction metadata is tested may be based on a predicted time of receipt of the authorization information. The transaction metadata and authorization information may be correlated. A computing device may determine whether to authorize the financial transaction based on the authorization information and the correlated transaction metadata. All or portions of the transaction metadata may be provided to one or more users after the transaction has been authorized or denied.

Abstract: Methods, systems, and apparatuses are described herein for the direct sharing and use of transaction data separately from transaction authorization processes. Transaction metadata associated with a transaction may be received and validated. Authorization information corresponding to the transaction may be received. The degree to which the transaction metadata is tested may be based on a predicted time of receipt of the authorization information. The transaction metadata and authorization information may be correlated. A computing device may determine whether to authorize the financial transaction based on the authorization information and the correlated transaction metadata. All or portions of the transaction metadata may be provided to one or more users after the transaction has been authorized or denied.

Abstract: Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.

Abstract: The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.

Abstract: A transparent plastic container comprising an aqueous liquid laundry detergent composition wherein the liquid detergent composition comprises: from 5 to 60 wt. % of surfactant; and from of 0.0005 to 0.01 wt. % of an amylase and/or from 0.0005 to 0.01 wt. % of a protease; and from 0.00005 to 0.02 wt. % of a dye comprising an anthraquinone chromophore which contains an amine group or an acid amide group in the 1-position of the anthraquinone ring; and wherein the container has an internal volume of from 0.1 to 10 L.

Abstract: There are disclosed inter alia antigen pools which are useful in the treatment of cancer, particularly melanoma, especially cutaneous melanoma and uveal melanoma.

Abstract: There are disclosed inter alia fusion proteins and nucleic acids encoding said fusion proteins which are useful in the treatment and prevention of cancer, particularly melanoma, especially cutaneous melanoma and uveal melanoma.

Abstract: A model can be trained for discriminant analysis for substance classification and/or measuring calibration. One method includes interacting at least one sensor with one or more known substances, each sensor element being configured to detect a characteristic of the one or more known substances, generating an sensor response from each sensor element corresponding to each known substance, wherein each known substance corresponds to a known response stored in a database, and training a neural network to provide a discriminant analysis classification model for an unknown substance, the neural network using each sensor response as inputs and one or more substance types as outputs, and the outputs corresponding to the one or more known substances.

Abstract: The present disclosure relates to devices and methods for providing access to graphics or compute hardware acceleration to applications executing in a guest environment. The devices and methods may provide virtualization support to graphics or compute devices so that graphics or compute devices may be projected inside of a guest environment. The devices and methods may share the physical resources for graphics and compute hardware acceleration by coordinating the use of the graphics or compute hardware acceleration across a spectrum of devices, environments, or platforms.

Abstract: Described is a method of manufacturing carboxymethyl cellulose (CMC) fibres containing an antimicrobial, the fibres being suitable for use in the preparation of wound dressings, wherein the antimicrobial is selected from the group consisting of a biguanide, a biguanide derivative, octenidine, taurolidine, and a combination of two or more thereof, the method comprising, submerging CMC fibres comprising at least 95 wt % carboxymethylcellulose on a dry weight basis in a treatment solution for a duration adequate to provide the CMC fibres containing an antimicrobial, the treatment solution comprising the antimicrobial and at least 70 wt % of a water-miscible organic solvent selected from C1-C4 alkanols, C3-C5 ketones, and a combination of two or more thereof. Anti-microbial CMC fibres obtained by the methods and wound dressings containing such fibres are also described.

Abstract: A method of operating an accessory drive system for a motor vehicle, wherein the accessory drive system includes one or more accessory components, a motor generator of the motor vehicle, and a flexible drive element configured to transmit a torque load between the one or more accessory components and the motor generator, includes determining a maximum permissible flexible drive element torque threshold, detecting an increase in torque demand on the flexible drive element, determining when the torque demand on the flexible drive element will exceed the flexible drive element torque threshold, and reducing the torque demand of one or more of the accessory components so that the flexible drive element torque threshold is not exceeded.